CVS Health (CVS) Tops Q2 EPS by 36c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CVS Health Reports Strong Second Quarter Results
August 4, 2021 6:30 AM EDTWOONSOCKET, Rhode Island, Aug. 4, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2021.
Second Quarter Highlights:
Total revenues increased to $72.6 billion, up 11.1% compared to prior year GAAP diluted EPS of $2.10 and Adjusted EPS of $2.42Year-to-date Highlights:
Total revenues increased to $141.7 billion, up 7.3% compared to prior year GAAP diluted EPS of $3.78 and Adjusted EPS of $4.46 Generated cash flow from operations of $8.7 billion Repaid $5.4... More